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We performed a molecular study with 21 microsatellites on a sample of 82 trisomy 13 conceptuses, the
largest number of cases studied to date. The parental origin was determined in every case and in 89% the
extra chromosome 13 was of maternal origin with an almost equal number of maternal MI and MII errors.
The latter finding is unique among human autosomal trisomies, where maternal MI (trisomies 15, 16, 21,
22) or MII (trisomy 18) errors dominate. Of the nine paternally derived cases five were of MII origin but
none arose from MI errors. There was some evidence for elevated maternal age in cases with maternal meio-
tic origin for liveborn infants. Maternal and paternal ages were elevated in cases with paternal meiotic origin.
This is in contrast to results from a similar study of non-disjunction of trisomy 21 where paternal but not
maternal age was elevated. We find clear evidence for reduced recombination in both maternal MI and MII
errors and the former is associated with a significant number of tetrads (33%) that are nullichiasmate,
which do not appear to be a feature of normal chromosome 13 meiosis. This study supports the evidence
for subtle chromosome-specific influences on the mechanisms that determine non-disjunction of human
chromosomes, consistent with the diversity of findings for other trisomies.
INTRODUCTION
Trisomy 13, or Patau syndrome, was first described by Patau
et al. (1). With prevalence rates at birth estimated between
1/4000 and 1/29 000 (2,3), Patau syndrome is the third most
common autosomal trisomy among newborns, after Down
syndrome and Edwards syndrome. Trisomy 13 occurs in
2% of first trimester spontaneous abortions, where it is the
fourth commonest autosomal trisomy following those of
chromosomes 16, 21 and 22 (4). Clinical findings in Patau
syndrome include severe mental and growth retardation, as
well as varying combinations of microcephaly, ocular malfor-
mations, polydactyly, cleft lip and/or palate, omphalocele,
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cardiac and renal anomalies, leading to a 95% mortality rate
within the first year of life (2,3). As with the autosomal triso-
mies 16, 18 and 21, there is a strong association with increased
maternal age (4).
Trisomy 13 occurs with either a free additional chromo-
some 13 or as a Robertsonian translocation involving a
chromosome 13, usually a de novo translocation t(13;14) or
t(13;13) or as an isochromosome i(13;13). DNA studies of
the parental origin of the additional chromosome 13 in cases
of free trisomy 13 have, to date, been undertaken using
RFLP markers and microsatellites in a very limited number
of cases: RFLP markers: 8 cases (5); microsatellites: 27
cases (6) and 19 cases (7). In those studies it was not possible
to determine the parental origin in all cases, and it was only
possible to determine the meiotic stage of non-disjunction in
a fraction of the cases.
We investigate here a total of 82 trisomy 13 cases. This is
by far the largest sample of trisomy 13 cases examined to
date and enables the determination of parental origin and
meiotic stage of non-disjunction of the extra chromosomes.
We have also constructed non-disjunction maps for this
chromosome for the first time to evaluate whether patterns
of recombination are altered in the trisomic cases, as has
been found in other trisomies.
RESULTS
Patient populations
The sample comprises 82 trisomy 13 conceptuses and their
parents. Although 5 families came from Norway, 4 from Swit-
zerland, 4 from France, 6 from Belgium and one from Greece,
the majority of 62 were from Denmark. A total of 50 cases
were obtained through routine prenatal diagnosis, along with
26 live births, four spontaneous abortions and two stillborn
children (Table 1).
Cytogenetic analysis
The karyotypes of the probands are 47,XX,þ 13 in 34 cases,
47,XY,þ 13 in 46 cases, 46,XX/47,XXþ 13 in one and
47,XYþ 13/48,XYYþ 13 in one case. The karyotypes of all
parents were normal, except for one father who was carrier
of a rob(13;14). The child of this father had a free trisomy
13 of maternal origin.
Parental origin and cell division error
Tables 2 and 3 give a breakdown of parental origin by meiotic
stage. From the total of 82 cases, 73 are of maternal origin
(89%) with an almost equal number of errors in the first and
second meiotic stages (MI: 34 and MII: 33), and 3 are con-
sidered to be post-zygotic mitotic (PZM) errors. The majority
of the nine paternally derived cases are due to meiotic errors,
as five are MII, one unknown, but most likely to be MII and
three most likely to be PZM (Tables 2 and 3). In five of the
six cases originating from meiotic paternal errors the probands
were males and only one was a female, and the three cases due
to paternal mitotic error were all males.
Maternal age
The maternal ages and maternal ages by cell division error are
given in Tables 1 and 3. Nearly one-third of the conceptuses
were ascertained by prenatal diagnosis because of advanced
maternal age (35 years and older). Of the 26 live births, 19
were Danish and, with one exception, the mothers were all
younger than 35 years at the time of conception (mean maternal
Table 2. Classification of cases by parental origin and meiotic error
Meiotic stage of error
MI(t) MI(n) MI(?) MII(t) MII(n) MII(?) PZM Unknown meiotic stage Total
Maternal 17 13 4 29 3 1 3 3 73
Paternal 0 0 0 5 0 0 3 1 9
Total 17 13 4 34 3 1 6 4 82
(t), cases with one or more transitions; (n), nulli-chiasmate cases; (?), cases where meiotic stage determined but fewer than seven markers informative
about transition distribution.
Table 1. Study population
Ascertainment Number of cases Maternal age (mean+ SD)
Total Female Male M/F ratio
Prenatal advanced age 25 14a 11 0.8 38.1+ 2.6
Prenatal other 25 8 17 2.1 30.3+ 3.1
Spontaneous abortions 4 2 2 1 35.8+ 5.3
Live birth 26 10 16b 1.6 30.7+ 4.3
Stillbirth 2 1 1 1 34.5+ 3.5
Total 82 35 47 1.3 33.1+ 5.0
aIncluding one case with 46,XX/47,XXþ 13.
bIncluding one case with 47,XY,þ13/48,XYY,þ13.
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age 30.5).We analysedmaternal ages for theDanish cases,where
we have detailed information about national maternal ages. The
Danish cases were born in the period 1984–2004, during which
the national mean maternal age for mothers in Denmark varied
between 27.5 and 30.2 years (overall mean 28.9) and from 26.5
to 28.8 years (overall mean 27.9), excluding those who are 35
years or more at the time of childbirth (8). AWilcoxon matched-
pairs comparison of the 19 maternal ages with corresponding
national mean ages yields P, 0.0874 and P, 0.00823 when
national means exclude those aged .35. There is therefore a
suggestion that the mean maternal age is still elevated when the
cases ascertained because of advancedmaternal age are excluded.
The mean maternal age is elevated for spontaneous abor-
tions and stillbirths, but these groups represent only six
cases in total. There is no difference in the mean maternal
age for mothers of maternal meiosis I and II errors. The
parents of the six cases with paternal meiotic errors have
advanced parental age as the mean maternal age is 32.5 and
the mean paternal age is 39.0 years.
The frequency of nullichiasmate tetrads
The frequency of nullichiasmate tetrads was examined in both
normal meiosis and non-disjunction (Table 4). There is no evi-
dence for nullichiasmate tetrads in both normal chromosome
13 meiosis and MII trisomy cases (x2 0–1.42), but strong evi-
dence for nullichiasmate tetrads in 33% of maternal MI cases
(x2 6.74, P , 0.01).
Non-disjunction maps
Figure 1 compares non-disjunction maps from the maternal
cases with the standard linkage map. The standard map
comprises 21 markers between HECH1 and D13S285 and
spans 156.04 cM. Both non-disjunction maps are shorter
than the standard map (MI: 132.65 cM +19.45; MII:
125.23 cM +12.74). Relative to the standard map differences
in the slopes of the non-disjunction maps suggest regional dis-
tortions in the recombination rate. Both MI and MII maps
show increased recombination close to the centromere (the
first 0–20 cM on the standard map). The central portion of
13q shows some regions with markedly reduced recombina-
tion in both MI and MII, although MI shows some evidence
for locally elevated rates at around the 50 cM point on the
standard map. The maps provide compelling evidence for a
distorted recombination pattern in both maternal MI and MII
non-disjunction.
DISCUSSION
The additional chromosome 13 arose from maternal non-
disjunction in 89% of the cases. This is consistent with
results found in previous non-disjunction studies of trisomy
13 (Table 5). The distribution of maternal MI and MII errors
shows an equal number of the two (Tables 2 and 3). This
finding has not been reported in previous studies of this
chromosome, as the authors were not able to distinguish
between meiosis I and II errors in the majority of cases,
because chromosome 13 was poorly mapped in the pericentro-
meric region. We therefore constructed PCR primers around a
(CA)n repeat situated very close to the centromere (HECH1)
and using this and nearby concordant markers, the meiotic
stage was assigned in all but four cases (Table 2).
The finding of approximately equal numbers of both
meiotic stage errors in maternal meiosis is unique among auto-
somal trisomies, as maternal MI errors are dominant in
trisomy 16 (9), 21 (10) and 22 (6), and maternal MII errors
dominate in trisomy 18 (11) (Table 6). However, Lamb
et al. (12) indicated that some trisomy 21 cases with apparent
maternal meiosis II errors could reflect a precipitating event in
meiosis I. This is recognized by increased recombination in
the pericentromeric region evident in the maternal MII map
and the possibility that bivalents with proximal exchanges
become ‘entangled’ and are therefore misclassified as MII
errors. For chromosome 13, we have shown increased recom-
bination in the pericentromeric region in both maternal MI and
MII maps. It is possible that the same mechanism might take
place in trisomy 13 in which case the relative proportions of
MI and MII errors cannot be known with certainty.
The paternal meiotic error rate of 11% is higher than in
studies of trisomy 16, 18 and 21, where the paternal error
rate is 0, 6 and 7%, respectively, (Table 6). No case arose
through paternal MI non-disjunction (Tables 2 and 3). This
result contrasts with trisomy 21, where one-third of the
paternal meiotic errors are MI and two-thirds are MII errors,
but the result is similar to the results of studies of the other
acrocentric trisomies for chromosomes 14, 15 and 22 (6),
although samples sizes investigated in these trisomies were
very small (Table 6).
In Denmark an invasive prenatal procedure was offered to
all pregnant women aged 35 years or more at the time of con-
ception of pregnancy until the year 2004. The uptake was high
for this group, especially in the early 1990s (13). In spite of
this we have suggestive evidence that maternal age is some-
what elevated for the 19 Danish live births. We also find
advanced maternal and paternal age in cases of paternal
meiotic origin (Table 3). This has been observed in non-
disjunction studies of trisomy 13, 14, 15 and 22 (6), but is
in contrast to results from trisomy 21 studies, where the
maternal age was significantly lower in cases of paternal
meiotic origin than of maternal meiotic origin (13), and in a
study of 47,XXY and 47,XXX where there was no evidence
of increased paternal age in the aneuploids of paternal origin
(14). In the cases due to paternal non-disjunction there is an
Table 3. Maternal age and cell division error
Cell division All cases Excluding prenatal cases ascertained
because of advanced maternal age
No Maternal age
(meanþ SD)
No Maternal age
(meanþ SD)
All 82 33.1+ 5.0 54 31.1+ 4.1
Maternal MI 34 33.6+ 4.4 23 31.7+ 3.8
Maternal MII 33 33.8+ 5.7 22 31.2+ 4.7
Maternal PZM 3 28.0+ 3.6 3 28.0+ 3.6
Maternal MI or MII 3 33.5+ 4.0 2 31.5+ 2.1
Paternal MII 5 33.8+ 1.3 3 33.0+ 0.8
Paternal PZM 3 32.3+ 6.0 2 29.5+ 3.5
Paternal MI or MII 1 26
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excess of males. A similar observation has been described in a
study of paternal non-disjunction of trisomy 21, where 21 of
36 probands were males (15).
Examination of the maternal MI non-disjunction map indi-
cates reduced recombination compared with the standard map
(85% of the overall length). This in part reflects a high
number of nullichiasmate tetrads (33%) which do not appear
to be a feature of normal chromosome disjunction or tetrads
giving rise to maternal MII errors. Interestingly, Tease et al.
(16), examining MLH1 foci at the pachytene stage, observed
no (presumed non-cross-over) oocytes lacking foci for
chromosome 13, except in abnormal cells which showed
chromosome pairing errors. The authors suggested that these
abnormal fetal oocytes were the source of maternal non-
disjunction errors. A similar finding of nullichiasmate tetrads
has been reported previously, for example, Robinson et al.
(17) estimated that 21% of tetrads leading to maternal MI non-
disjunction were nulli-chiasmate on chromosome 15.
Although the overall recombination rate is lower than the
standard map across the chromosome (Fig. 1), there is a sug-
gestion of increased intensity of recombination in the centro-
meric region. Some evidence for increased centromeric
recombination was previously reported in chromosome 21
maternal meiosis II (12). Chromosome 18 non-disjunction is
associated with even greater suppression of recombination as
the maternal MI map is only 62% of the length of the standard
map (11). Other chromosomes show the same features with
varying degrees of intensity. The maternal MI map is 46 and
75% of the standard map length for chromosomes 21 and
16, respectively (9,18). Chromosome 15 shows reduced
recombination in maternal MI non-disjunction, especially on
proximal 15q (19).
While there is some consistency across chromosomes with
suppressed recombination in maternal MI errors this is less
true for maternal MII errors. We observe an overall suppres-
sion of recombination, similar to that observed for MI but
apparently more uniform along the chromosome length
(Fig. 1). The overall length is 80% that of the standard map.
For trisomy 21 map length is 1.46þ /20.11 times the standard
map, mostly the result of increased proximal recombination
(18). Although MacDonald et al. (14) reported an overall
decrease in recombination in maternal MII X chromosome
trisomy there is little published evidence for suppression of
recombination associated with maternal MII errors.
Figure 1. Maternal non-disjunction maps of chromosome 13. The figure plots meiosis I and II maternal non-disjunction maps against the standard linkage map
on the X-axis. Increases and decreases in slope relative to the standard map indicate, respectively, increased and reduced recombination rates in the non-
disjunction maps.
Table 4. The numbers of cross-overs and transitions in chromosome 13 meiosis
Data q0 x2 (q0 ¼ 0) n0 n1 n2 n3 n4 n5 Total Reference source
Pat. cross. 0.07 0.46 29 36 13 0 0 0 78 (11)
Pat. MII 0.00 0.00 0 2 1 1 1 0 5
Mat. cross. 0.12 1.42 21 27 21 9 0 0 78 (11)
Mat. MI 0.33 6.74 13 3 7 4 3 0 30
Mat. MII 0.09 0.00 3 11 7 7 3 1 32
cross., cross-over distribution in normal meiosis from CEPH families; q0, frequency of nulli-chiasmate tetrads; n0–n5 ¼ counts of cross-overs and
transitions.
P, 0.01 excludes cases with fewer than seven markers informative.
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However, for chromosome 18 a slightly, but not significantly,
reduced map length in maternal MII errors was observed (11).
The possibility that at least a proportion of apparent MII errors
reflect a precipitating even in MI, following Lamb et al. (12),
would of course, have implications for the interpretation of
these maps.
For the maternal MI and MII samples we find no evidence
for a relationship between increasing number of transitions
and mean maternal age as reported for trisomy 15 by Robinson
et al. (19) (data not shown).
Chromosome 13 non-disjunction arises mostly through
maternal meiotic errors, consistent with other trisomies,
although, unusually there are equal numbers of MI and MII
stage errors. There is strong evidence for suppressed recombi-
nation arising, at least in part, from nullichiasmate tetrads in
MI as has been observed in other trisomies. There is less evi-
dence for suppression of recombination associated with MII
stage errors in other trisomies but it is observed for trisomy
13. However, elevated pericentromeric recombination sup-
ports the possibility that a proportion of the MII cases arose
due to an error at MI. Difficulties of interpretation such as
this may contribute to some of the differences in patterns of
non-disjunction observed between chromosomes. One consist-
ent finding for human trisomy, supported by our study, is that
of altered recombination but establishing cause and effect is
challenging. We conclude that while there are shared mecha-
nisms there are subtle chromosome-specific differences in
patterns of chromosome non-disjunction manifested as differ-
ences in recombination and variations in the meiotic stage
associated with the errors.
MATERIALS AND METHODS
DNA analysis
DNA from the probands was extracted from cultured chorionic
villi, amniocytes, blood, cultured fetal tissues or skin fibro-
blasts, and in two cases from paraffin embedded tissue by
routine methods. Parental DNA was extracted from
EDTA-anticoagulated blood by routine methods. In one case
no sample was available from the mother. Twenty-one DNA
polymorphisms were detected after PCR amplification of
genomic DNA. End-labeling of primer, PCR amplification
conditions, PAGE of the amplification products and auto-
radiography were performed according to protocols described
elsewhere (20). The microsatellites used were the (CA)n
repeats at the following loci: D13S115 and D13S141 (21);
D13S175, D13S171, D13S218, D13S155, D13S176,
D13S156, D13S170, D13S154 and D13S173 (22), D13S71
(23), D13S118 and D13S120 (24), D13S1316, D13S217,
D13S174, D13S1265, D13S285 (25) and the (TG)n repeat of
the human fms-related tyrosine kinase gene FLT1 (26).
The microsatellite HECH 1: In order to resolve potential
cross-over events close to the centromere, the pericentromeric
region on chromosome 13q was scanned for repetitive regions
suitable for microsatellite analysis. Primers were designed
using Oligo software (Moleculart Biology Insights, West
Cascade, CO, USA). A single region flanked by primers
mb1A: 50-TTGCAGCATTTTATATAAGATGTTT-30 and
mb1B: 50-TGTTTGAACTGAAGTTTTAAGGAT-30 am-
plifying a 217 bp fragment, including a polymorphic
Table 6. Parental origin and meiotic error of different autosomal trisomies
Trisomy Total number
of cases
Maternal meiotic origin Paternal meiotic origin Paternal mitotic origin Paternal origin all
MI, n
(% of total)
MII, n
(% of total)
MI/MII, n
(% of total)
MI, n
(% of total)
MII, n
(% of total)
MI/MII, n
(% of total)
n
(% of total)
n
(% of total)
21 (10) 807 556(69) 176(22) 0 17(2.1) 27(3.3) 0 14(1.7) 58(7.2)
18 (11,35) 217 61(28) 105(48) 0 0 1(0.5) 2(0.9) 9(4) 12(5.5)
16 (9) 62 62(100) 0 0 0 0 0
14 (6) 12 3(25) 4(33) 2(16) 0 2(16) 0 2(17)
15 (6,17) 49 26(53) 5(10) 8(16) 0 1(1) 1(2) 5(10) 7(14)
15 (19) mUDP 115 97(84) 19(16) 0 0 0
22 (6) 19 6(32) 0 11(58) 0 0 2(10) 0 2(10.5)
13 (present study) 82 34 (41) 33 (40) 3(4) 0 5 (6) 1(1) 3(4) 9(11)
Percentages in brackets. Cases of maternal mitotic postzygotic origin are excluded.
mUPD, ascertained as maternal uniparental disomy for chromosome 15.
Table 5. The present sample and published trisomy 13 cases classified by DNA analysis
Number of cases Maternal error Maternal Mitotic Paternal error Paternal mitotic
MI MII MI/MII MI MII MI/MII
Hassold et al. (5) 7 3 2 0 0 2 0 0 0
Zaragoza et al. (6) 22a 4 0 15 1 1 1 0 0
Robinson et al. (7) 19 0 0 15 2 0 0 0 2
Present study 82 34 33 3 3 0 5 1 3
Total 130 41 35 33 6 3 6 1 5
a27 cases in total, but three cases were already described in Hassold et al. (5), and in two cases the parental origin was unknown.
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CA-dinucleotide repeat (rs10551654) was chosen for further
analysis.
Classification of cases
The parental origin of the three chromosomes was determined
by scoring the polymorphic alleles, when three different
alleles were present in the proband, and by dosage analysis
scored by visual comparison, when two different alleles
were present in the proband (27).The meiotic stage of non-
disjunction was determined on the basis of reduction (or
not) to homozygosity at the pericentromeric 13q markers
HECH1, D13S1316 or D13S141, using the methods of
Chakravarti and Slaugenhaupt (28) and Chakravarti (29).
The HECH1 centromere marker was informative in most
cases but in a small number of cases the two most proximal
markers had to be used for classification. The three markers
span 0.92 cM on the standard map and were concordant
throughout, except in one case where there was a transition
between D13S1316 and D13S141, raising the possibility that
a small number of cases, in the subset not informative at
HECH1, were misclassified.
Distinguishing PZM cases and any nulli-chiasmate MII
cases, should they arise, is not possible. In the sample there
are three paternal PZM cases, one of which is a mosaic. As
there is no evidence to suggest there is a sex difference in
the numbers of PZM cases we assumed equal numbers of
paternal and maternal PZM, as assumed for trisomy 18 (11).
We observed six maternal nulli-chiasmate MII or PZM
cases. One was a mosaic, which we classified as PZM. As
there is evidence (30) that maternal age is not advanced in
PZM cases, the two other cases with young mothers, both
,30 years, were also classified as PZM. The remaining
three ambiguous maternal cases were tentatively classified as
nullichiasmate MII.
Chiasma distribution
Following Bugge et al. (11), we re-constructed the chiasma
distribution (Table 4) using the program Exchange (Available
on request from Andrew Collins). This enables comparison of
the frequency of nullichiasmate tetrads in both MI and MII
cases with the cross-over distribution.
Non-disjunction mapping
Non-disjunction maps were constructed for the maternal MI
and MII data using the mapþ program (31). Heterozygous
loci in the parent contributing the additional chromosome
were classified in the trisomic proband as either as ‘N’ (not
reduced to homozygosity) or ‘R’ (reduced to homozygosity).
In this way, transitions between reduced and non-reduced
states could be reliably determined given sufficient coverage
by informative markers. For non-disjunction mapping, we
did not use cases with fewer than seven markers informative
(Table 4). The theory for the analysis of tetrads follows
Shahar and Morton (32) and is implemented in the mapþ
program (11). Using mapþ , we computed the interference
parameter p in the Rao function for the standard female map
of chromosome 13 as 0.23, corresponding to a relatively
high level of chiasma interference (33). The truncation
parameter T, beyond which pairs of loci are separated by
more than one recombination value (11), was computed at
55 cM given the estimated level of chiasma interference.
Maternal MI and MII non-disjunction maps were constructed
using the data for which meiotic stage and number of tran-
sitions could be reliably determined.
Comparison of non-disjunction and standard
female genetic maps
We examined and compared patterns of maternal recombina-
tion in a standard genetic map with non-disjunction maps con-
structed from the informative MI cases (N ¼ 30) and MII
cases (N ¼ 32) (Table 2). There were insufficient paternal
cases across both samples to construct non-disjunction maps.
Standard map. The standard female linkage map of chromo-
some 13 was constructed from the data from Icelandic families
collected by Kong et al. (34).This comprised a total of 21
polymorphic markers typed and ordered by physical location
in build 35 of the human genome sequence between
17308.183 kb (HECH1) and 110743.481 kb (D13S285). The
standard female map spans 156.04 cM (Fig. 1). Where
genetic locations were not known directly, they were inferred
by interpolation between genetic map flanking markers and
using known physical locations.
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